Edition:
United Kingdom

Jiangsu Hengrui Medicine Co Ltd (600276.SS)

600276.SS on Shanghai Stock Exchange

69.35CNY
6:59am GMT
Change (% chg)

¥3.92 (+5.99%)
Prev Close
¥65.43
Open
¥66.74
Day's High
¥69.49
Day's Low
¥66.30
Volume
24,370,071
Avg. Vol
10,645,212
52-wk High
¥76.92
52-wk Low
¥37.25

Latest Key Developments (Source: Significant Developments)

Jiangsu Hengrui Medicine passes U.S. FDA approval
Wednesday, 29 Nov 2017 

Nov 29(Reuters) - Jiangsu Hengrui Medicine Co Ltd <600276.SS>:Says it received FDA approval for Dexmedetomidine Hydrochloride Injection from U.S. Food and Drug Administration.Company will be able to sell its Dexmedetomidine Hydrochloride Injection in the United States after receiving the FDA approval.  Full Article

Jiangsu Hengrui Medicine gets approval for clinical trials of drugs
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Jiangsu Hengrui Medicine Co Ltd <600276.SS>:Says it gets clinical trials approval for its drug named Seebri® Breezhaler® from China Food and Drug Administration.  Full Article

Jiangsu Hengrui Medicine's 9-month net profit up 20.7 pct y/y
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Jiangsu Hengrui Medicine Co Ltd <600276.SS>:Says 9-month net profit up 20.7 percent y/y at 2.3 billion yuan ($347.33 million).  Full Article

Jiangsu Hengrui Medicine to pay A shares annual div for FY 2016 on May 31
Monday, 22 May 2017 

May 22 (Reuters) - Jiangsu Hengrui Medicine Co Ltd <600276.SS> ::* Says it will pay cash dividend of 0.135 yuan(before tax)/share and use additional paid-in capital to distribute 0.2 new shares/share for 2016 to shareholders of record on May 26 .* The company's shares will be traded ex-right and ex-dividend on May 31 and the dividend will be paid on May 31.  Full Article

Jiangsu Hengrui Medicine's H1 net profit up 24 pct y/y
Monday, 29 Aug 2016 

Jiangsu Hengrui Medicine Co Ltd <600276.SS> :Says H1 net profit up 23.85 percent y/y at 1.3 billion yuan ($194.66 million).  Full Article

Jiangsu Hengrui Medicine and unit receive approval for drug clinic trial
Tuesday, 5 Jul 2016 

Jiangsu Hengrui Medicine <600276.SS> Co., Ltd.:Says the co and unit get China Food and Drug Administration's approval for its SHR-1314 injection which will be mainly used for the treatment of psoriasis.  Full Article

Jiangsu Hengrui Medicine says 2015 dividend payment date
Wednesday, 8 Jun 2016 

Jiangsu Hengrui Medicine Co Ltd <600276.SS>: Says it will pay a cash dividend of 1 yuan (pre-tax) for every 10 shares and to distribute 2 shares for every 10 shares as stock dividend, to shareholders of record on June 15 for 2015 .Says the company's shares will be traded ex-right and ex-dividend on June 16 and the dividend will be paid on June 16.  Full Article

Jiangsu Hengrui Medicine unit gets nod for clinic trial
Saturday, 30 Apr 2016 

Jiangsu Hengrui Medicine Co Ltd:Says its unit gets China Food and Drug Administration's approval for its tafluprost' clinic trial.  Full Article

Jiangsu Hengrui Medicine unit gets nod for clinic trial
Tuesday, 19 Apr 2016 

Jiangsu Hengrui Medicine Co Ltd:Says its unit gets China Food and Drug Administration's approval for its istradefylline pills' clinic trial.  Full Article

Jiangsu Hengrui Medicine announces 2015 dividend payment
Wednesday, 13 Apr 2016 

Jiangsu Hengrui Medicine Co Ltd:Says it will use undistributed profits to pay a cash dividend of 1 yuan (pre-tax) per 10 shares to shareholders for the 2015.Says to distribute 2 new share for every 10 shares as stock dividends.  Full Article

BRIEF-Jiangsu Hengrui Medicine passes U.S. FDA approval

* Says it received FDA approval for Dexmedetomidine Hydrochloride Injection from U.S. Food and Drug Administration